Super Bolus: a remedy for a high glycemic index meal in children with type 1 diabetes on insulin pump therapy?-study protocol for a randomized controlled trial

Emilia Kowalczyk, Katarzyna Dżygało, Agnieszka Szypowska, Emilia Kowalczyk, Katarzyna Dżygało, Agnieszka Szypowska

Abstract

Background: Postprandial hyperglycemia (PPH) is a common clinical problem among patients with type 1 diabetes (T1D), which is related to high glycemic index (h-GI) meals. The main problem is linked to high, sharp glycemic spikes following hypoglycemia after h-GI meal consumption. There is a lack of effective and satisfactory solutions for insulin dose adjustment to cover an h-GI meal. The goal of this research was to determine whether a Super Bolus is an effective strategy to prevent PPH and late hypoglycemia after an h-GI meal compared to a Normal Bolus.

Methods: A total of 72 children aged 10-18 years with T1D for at least 1 year and treated with continuous subcutaneous insulin infusion for more than 3 months will be enrolled in a double-blind, randomized, crossover clinical trial. The participants will eat a h-GI breakfast for the two following days and receive a prandial insulin bolus in the form of a Super Bolus 1 day and a Normal Bolus the next day. The glucose level 90 min after the administration of the prandial bolus will be the primary outcome measure. The secondary endpoints will refer to the glucose levels at 30, 60, 120, 150, and 180 min postprandially, the area under the blood glucose curve within 180 min postprandially, peak glucose level and the time to peak glucose level, glycemic rise, the mean amplitude of glycemic excursions, and the number of hypoglycemia episodes.

Discussion: There are still few known clinical studies on this type of bolus. A Super Bolus is defined as a 50% increase in prandial insulin dose compared to the dose calculated based on the individualized patient's insulin-carbohydrate ratio and a simultaneous suspension of basal insulin for 2 h. Our patients reported the best experience with such a combination. A comprehensive and effective solution to this frequent clinical difficulty of PPH after an h-GI meal has not yet been found. The problem is known and important, and the presented solution is innovative and easy to apply in everyday life.

Trial registration: ClinicalTrials.gov NCT04019821.

Keywords: High glycemic index; Postprandial hyperglycemia; Super Bolus.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

References

    1. DiMeglio LA, Acerini CL, Codner E, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes. 2018;19:105–114. doi: 10.1111/pedi.12737.
    1. Lee I, Lunt H, Chan H, et al. Postprandial capillary–venous glucose gradient in Type 1 diabetes: magnitude and clinical associations in a real world setting. Diabeti Med. 2015;33:998–1003. doi: 10.1111/dme.13025.
    1. Deeb A, Al Hajeri A, Alhmoudi I, et al. Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes. 2016;18:903–910.
    1. Cresswell P, Krebs J, Gilmour J, et al. From ‘pleasure to chemistry’: The experience of carbohydrate counting with and without carbohydrate restriction for people with type 1 diabetes. J Prim Health Care. 2015;7:291–298. doi: 10.1071/HC15291.
    1. Bell KJ, Gray R, Munns D, et al. Clinical Application of the Food Insulin Index for Mealtime Insulin Dosing in Adults with Type 1 Diabetes: A Randomized Controlled Trial. Diabetes Technol Ther. 2016;4:2018–2025.
    1. Smart CE, Ross K, Edge JA, et al. Can children with type 1 diabetes and their caregivers estimate the carbohydrate content of meals and snacks? Diabeti Med. 2010;27:348–353. doi: 10.1111/j.1464-5491.2010.02945.x.
    1. Smart CE, Ross K, Edge JA, et al. Children and adolescents on intensive insulin therapy maintain postprandial glycaemic control without precise carbohydrate counting. Diabet Med. 2009;26:279–285. doi: 10.1111/j.1464-5491.2009.02669.x.
    1. Smart CE, King BR, Mcelduff P, et al. In children using intensive insulin therapy, a 20-g variation in carbohydrate amount significantly impacts on postprandial glycaemia. Diabet Med. 2012;29:21–24. doi: 10.1111/j.1464-5491.2012.03595.x.
    1. Smart CE, Evans M, O'Connell SM, et al. Both dietary protein and fat increase postprandial glucose excursions in children with type 1 diabetes, and the effect is additive. Diabetes Care. 2013;36:3897–3902. doi: 10.2337/dc13-1195.
    1. O’Connell MA, Gilbertson HR, Donath SM, et al. Optimizing Postprandial Glycemia in Pediatric Patients With Type 1 Diabetes Using Insulin Pump Therapy. Diabetes Care. 2008;31:1491–1495. doi: 10.2337/dc08-0306.
    1. Bell KJ, Smart CE, Steil GM, et al. Impact of Fat, Protein, and Glycemic Index on Postprandial Glucose Control in Type 1 Diabetes: Implications for Intensive Diabetes Management in the Continuous Glucose Monitoring Era. Diabetes Care. 2015;38:1008–1015. doi: 10.2337/dc15-0100.
    1. James ML, Green L, Amiel SA, et al. Evaluation of the Effect of Carbohydrate Intake on Postprandial Glucose in Patients with Type 1 Diabetes Treated with Insulin Pumps. J Diabetes Sci Technol. 2016;10:1287–1293. doi: 10.1177/1932296816646797.
    1. Parillo M, Annuzzi G, Rivellese AA, et al. Effects of meals with different glycaemic index on postprandial blood glucose response in patients with Type 1 diabetes treated with continuous subcutaneous insulin infusion. Diabet Med. 2011;28:227–229. doi: 10.1111/j.1464-5491.2010.03176.x.
    1. Ryan RL, King BR, Anderson DG, et al. Influence of and Optimal Insulin Therapy for a Low–Glycemic Index Meal in Children With Type 1 Diabetes Receiving Intensive Insulin Therapy. Diabetes Care. 2008;31:1485–90.
    1. Johansen MD, Gjerløv I, Christiansen JS, et al. Interindividual and intraindividual variations in postprandial glycemia peak time complicate precise recommendations for self-monitoring of glucose in persons with type 1 diabetes mellitus. Journal of Diabetes Science and Technology. 2012;6:356-61.
    1. International Diabetes Federation Guideline Development Group. Guideline for management of postmeal glucose in diabetes. Diabetes Res Clin Pract. 2014;103:256-68.
    1. Calkins-Smith AK, Marker AM, Clements MA, et al. Hope and mealtime insulin boluses are associated with depressive symptoms and glycemic control in youth with type 1 diabetes mellitus. Pediatric Diabetes. 2018;19:1309-14.
    1. Rovner AJ, Nansel TR, Gellar L, et al. The effect of a low-glycemic diet vs a standard diet on blood glucose levels and macronutrient intake in children with type 1 diabetes. Journal of the American Dietetic Association. 2009;109:303-7.
    1. Nansel TR, Gellar L, McGill A, et al. Effect of varying glycemic index meals on blood glucose control assessed with continuous glucose monitoring in youth with type 1 diabetes on basal-bolus insulin regimens. Diabetes Care. 2008;31:695-7.
    1. Smart CE, Annan F, Higgins LA et al. ISPAD Clinical Practice Consensus Guidelines 2018: Nutritional management in children and adolescents with diabetes. Pediatric Diabetes. 2018;19:136-154.
    1. Luijf YM, van Bon AC, Hoekstra JB, et al. Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes. Diabetes Care. 2010;33:2152-5.
    1. Groele L, Golicki D, Błazik M, et al. Improving the Estimation of Meal-Time Insulin Dose Based On the Glycaemic Load of a Meal in Children with Type 1 Diabetes on Insulin Pump Therapy: A Randomized Study. J Diabetes Metab. 2014;5:435.
    1. Rosales N, De Battista H, Vehí J, et al. Open-loop glucose control: Automatic IOB-based super-bolus feature for commercial insulin pumps. Comput Methods Programs Biomed. 2018;159:145-58.
    1. Bondia J, Dassau E, Zisser H, et al. Coordinated basal-bolus infusion for tighter postprandial glucose control in insulin pump therapy. J Diabetes Sci Technol. 2009;3:89-97.
    1. Mayer-Davis EJ, Kahkoska AR, Jefferies C, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2018;19:7-19.
    1. Östman EM, Liljeberg Elmståhl HGM, Björck IME. Inconsistency between glycemic and insulinemic responses to regular and fermented milk products. The American Journal of Clinical Nutrition. 2001;74:96–100.
    1. Ioannidis JP, Evans SJ, Gøtzsche PC, et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med. 2004;141:781-88.
    1. Dzygalo K, Szypowska A. Impact of insulins glulisine and aspart on postprandial glycemia after a high-glycemic index meal in children with type 1 diabetes. Eur J Endocrinol. 2014;170:539-45.
    1. Fath M, Danne T, Biester T, et al. Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes. 2017;18:903-10.
    1. Haahr H, Heise T. Fast‑Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences. Clinical Pharmacokinetics. 2020;59:155–72.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel